Arnab Guha: New Insights into miRNA Therapies for Endometriosis and Depression
Arnab Guha, Founder, Director and Chief Visionary Officer at Impeccable Innovations Pvt. Ltd., shared a post on LinkedIn:
“Endometriosis induces depression in mouse models via miRNA dysregulation, leading to hippocampal shrinkage and reduced neurogenesis.
Targeting specific miRNAs – such as inhibitors for miR-125b and miR-451a, or a let-7b mimic – lowers depressive behaviors in tail suspension tests and restores hippocampal area, alongside upregulated genes like GAD45B, JUNB, ARC, and PROX1.
The findings build on prior research linking miRNAs like let-7b to endometriosis treatment in mice, suggesting potential miRNA-based therapies for alleviating psychological symptoms in affected patients.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 8, 2025, 06:17New E-Learning Module on Maternal Vaccinations Launched – RCOG
-
Dec 7, 2025, 18:25Thyroid Autoimmunity’s Impact on ART Outcomes Explored – CEOG
-
Dec 7, 2025, 18:23Join Us at the European Parliament on Fertility Crisis – Fertility Europe
-
Dec 7, 2025, 18:20ANDDE Joined The CNPGOGMA – New Era in Gynecology Collaboration – ANDDE
-
Dec 7, 2025, 18:17Gregory Piazza: New Perspectives on Antithrombotic Use During Pregnancy
-
Dec 7, 2025, 18:14New Insights Into Reproductive Health Using AI Technology – CEOG
-
Dec 7, 2025, 18:06Discover Latest Advances at the 2026 Gynecology and Obstetrics Fair – Gynécologie Obstétrique Pratique
-
Dec 7, 2025, 03:12Enhancing Progesterone Signaling in Endometrial Cells – Fertility and Sterility
-
Dec 7, 2025, 03:02Navigating Controversies in Polygenic Embryo Screening – ESHRE